Dr. David Rizzieri MD Medical Oncologist

Dr. David Rizzieri is a medical oncologist in Durham, North Carolina and is affiliated with Duke University Hospital. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice for 19 years. Dr. Rizzieri accepts several types of health insurance, listed below. He is one of 73 doctors at Duke University Hospital who specialize in Medical Oncology.

Are you Dr. David Rizzieri? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Clinical Interests: Myeloid Leukemia, Acute Myeloid Leukemia, Hodgkin Disease, Non-Hodgkin Lymphoma, Bone Marrow Transplantation

Hospital Affiliation

Duke University Hospital
Ranked #18 in Cancer

Education & Medical Training

University of Rochester
Residency, Internal Medicine, 1991 - 1994

Duke University Hospital
Fellowship, Hematology/Oncology, 1994 - 1997

University of Rochester School of Medicine and Dentistry
Class of 1991


Other Training, General Biology, 1983 - 1987

Certifications & Licensure

American Board of Internal Medicine
Certified 18 years in Internal Medicine

American Board of Internal Medicine
Certified 13 years in Internal Medicine

NC State Medical License

Awards, Honors & Recognition

Elected Member, The American Society for Clinical Investigation
2009

Senior Science Award, Hobart College
1987

Melvin J Shapiro Scholarship for excellence in Natural Sciences, Hobart College
1985

Publications & Presentations

MDS: unraveling the mystery
Rizzieri DA 2013 12 1

The genetic landscape of mutations in Burkitt lymphoma
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS 2012 11 1

Phase II Study of Cenersen, an Antisense Inhibitor of p53, in Combination with Fludarabine, Cyclophosphamide, and Rituximab for High Risk CLL
Lanasa MC, Davis PH, Datto M, Li Z, Gockerman JP, Moore JO, Decastro CM, Friedman DR, Diehl LF, Rehder C, Cook H, Daugherty FJ, Matta KM, Weinberg JB, Rizzieri D 2012 2 1

See all 90 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Kansas City Preferred-Care Blue PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.